PetMed Express Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PetMed Express stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View analyst ratings for PetMed Express or view top-rated stocks.

Wall Street analysts have given PetMed Express a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PetMed Express wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

PetMed Express is scheduled to release its next quarterly earnings announcement on Monday, July 19th 2021.
View our earnings forecast for PetMed Express.

PetMed Express, Inc. (NASDAQ:PETS) issued its quarterly earnings data on Sunday, May, 2nd. The company reported $0.34 EPS for the quarter, missing analysts' consensus estimates of $0.40 by $0.06. The company had revenue of $71.70 million for the quarter, compared to the consensus estimate of $74.04 million. PetMed Express had a net margin of 9.90% and a trailing twelve-month return on equity of 22.27%. PetMed Express's quarterly revenue was down 3.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.35 EPS.
View PetMed Express' earnings history.

PetMed Express' stock was trading at $25.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PETS shares have increased by 31.4% and is now trading at $34.11.
View which stocks have been most impacted by COVID-19.

PetMed Express declared a quarterly dividend on Monday, May 3rd. Stockholders of record on Friday, May 14th will be paid a dividend of $0.30 per share on Friday, May 21st. This represents a $1.20 dividend on an annualized basis and a dividend yield of 3.52%. The ex-dividend date of this dividend is Thursday, May 13th. This is an increase from PetMed Express's previous quarterly dividend of $0.28.
View PetMed Express' dividend history.

PetMed Express pays an annual dividend of $1.20 per share and currently has a dividend yield of 3.71%.
View PetMed Express' dividend history.

1 equities research analysts have issued 12 month price targets for PetMed Express' shares. Their forecasts range from $39.00 to $39.00. On average, they expect PetMed Express' stock price to reach $39.00 in the next twelve months. This suggests a possible upside of 14.3% from the stock's current price.
View analysts' price targets for PetMed Express or view top-rated stocks among Wall Street analysts.

5 employees have rated PetMed Express CEO Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among PetMed Express' employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to PetMed Express include Amazon.com (AMZN), Netflix (NFLX), Booking (BKNG), Expedia Group (EXPE), TripAdvisor (TRIP), Overstock.com (OSTK), 1-800-FLOWERS.COM (FLWS), Groupon (GRPN) and CarParts.com (PRTS).
View all of PETS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

PetMed Express' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.87%), Penserra Capital Management LLC (4.87%), Renaissance Technologies LLC (4.79%), Dimensional Fund Advisors LP (3.05%), Bank of New York Mellon Corp (1.86%) and Mirae Asset Global Investments Co. Ltd. (1.77%). Company insiders that own PetMed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends for PetMed Express.

PETS stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Renaissance Technologies LLC, Voloridge Investment Management LLC, Hussman Strategic Advisors Inc., Ameriprise Financial Inc., Dimensional Fund Advisors LP, Barclays PLC, and Baird Financial Group Inc.. Company insiders that have sold PetMed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag, and Ronald J Korn.
View insider buying and selling activity for PetMed Express or view top insider-selling stocks.

PETS stock was purchased by a variety of institutional investors in the last quarter, including Mirae Asset Global Investments Co. Ltd., Millennium Management LLC, BlackRock Inc., D. E. Shaw & Co. Inc., Guild Investment Management Inc., Formidable Asset Management LLC, Penserra Capital Management LLC, and Allianz Asset Management GmbH.
View insider buying and selling activity for PetMed Express or or view top insider-buying stocks.

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETS stock can currently be purchased for approximately $34.11.

PetMed Express has a market capitalization of $691.38 million and generates $309.21 million in revenue each year.

PetMed Express employs 214 workers across the globe.

The official website for PetMed Express is www.1800petmeds.com.

PetMed Express is headquartered at 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445.

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.